 |
Prospector
Profile
124-004
|
| |
| Human Biosystems, Inc. |
NAICS |
541711 |
| 1127 Harker Avenue
Palo Alto, CA 94301 |
Description |
Biotechnology |
| (650) 323-0943 |
Employees |
16 |
| http://www.humanbiosystems.com/ |
Revenue |
(mil) |
0.0000 |
| |
Income |
(mil) |
-2.7527 |
| |
Assets |
(mil) |
0.9190 |
| |
Liability |
(mil) |
1.3820 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Human Biosystems, Inc. had a net loss of $609,700 for the third quarter ended September 30, 2007, slightly lower than the net loss of $790,500 incurred during the third quarter ended September 30, 2006. For the nine months ended September 30, 2007, the Company had a $2,841,500 net loss, slightly higher than the $2,146,000 net loss reported during the same period in 2006. As a result of its recurring losses, the Company had an accumulated deficit of $26,059,300 as of September 30, 2007. It also has strained liquidity with only $35,600 in total current assets available to pay $1,591,900 in total current liabilities.
|
| |
|
Intellectual Property:
In July 2002, the Company received its first patent on the technology and methodology for preserving blood platelets. This patent, U.S. 6,413,713, B1, is titled "Method for Preserving Blood Platelets." In August 2003, the Company filed another patent application covering improved platelet preservation methods. In May 2006, the U.S. Patent Office approved the Company's patent for organ preservation entitled “Methods and Solutions for Storing Donor Organs,” U.S. Patent No. 7/029,839. As of March 2007, the U.S. Patent Office has granted the Company five patents for its organ, cell and platelet preservation technologies. [SEC Filing 10-KSB 04-02-2007]
|
| |
|
Description:
Human Biosystems, is a development stage company, which develops preservation platforms for organs, blood platelets, and other biomaterials.
|
| |
|
Officers:
Paul Okimoto (Chair, Sec. & VP); Harry Masuda (CEO); Dr. David Winter (Pres.); Dr. Luis Toledo (Chief Medical Officer); Dr. Larry McCleary (Dir.)
|
| |
|
Auditor:
L.L. Bradford & Company LLC
|
| |
|
Securities:
Common Stock-Symbol HBSC.OB; OTC BB; 109,804,500 common shares outstanding as of September 30, 2007.
|
| |
| |
| |
| return to main page |
|
|
